Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Compile real-world outcomes of commercially approved Intraceptâ„¢ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
The objective of this study is to compile real-world outcomes of commercially approved Intraceptâ„¢ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Inclusion Criteria:
Exclusion Criteria:
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
Flagstaff, Arizona 86001, United States
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890